Pharmacists in Billings, MT Accepting Medicare
186 Pharmacists found. Showing 181 - 186
 Mr. Craig Lewis Smart, PHARM. D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2290 King Ave W, Billings, MT 59102 Phone: 406-652-8556 Fax: 406-656-4069 |
Tyler J Vachal Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1330 Grand Ave, Billings, MT 59102 Phone: 406-252-0096 Fax: 406-252-3626 |
 Ashley Ann Hunter, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1649 Main St, Billings, MT 59105 Phone: 406-254-2947 Fax: 406-254-7365 |
Kathryn Egan, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 511 Central Ave, Billings, MT 59102 Phone: 406-245-4301 |
Rhett Godfrey, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2525 King Ave W, Billings, MT 59102 Phone: 406-652-9688 |
Jessica Mount Shotwell Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2525 King Ave W, Billings, MT 59102 Phone: 406-652-9688 |
News Archive
Study captures experiences of transgender and gender variant children and their parents
Amy Przeworski, assistant professor of psychology at Case Western Reserve University, and graduate student Jennifer Birnkrant will lead an online study that captures the experiences of transgender and gender variant children and their parents.
Surgeons identify rates of C. difficile infection in patients undergoing common colon operations
Clostridium difficile infection is the most common hospital-acquired infection and a significant cause of increased hospital stay and cost for patients and payors alike.
Nanofiber-based wound dressings loaded with vitamin D spur production of antimicrobial peptide
Nanofiber-based wound dressings loaded with vitamin D spur the production of an antimicrobial peptide, a key step forward in the battle against surgical site infections, or SSIs.
$1.6 million to develop gene therapy strategies for Duchenne muscular dystrophy, a fatal, childhood-onset disease
The Muscular Dystrophy Association has announced it has awarded $1.6 million to Asklepios, a biotechnology company closely allied with the University of North Carolina at Chapel Hill, to develop gene therapy strategies for Duchenne muscular dystrophy (DMD), a fatal, childhood-onset disease.
› Verified 8 days ago
Counselors
Pharmacists
Dentists
Clinical Social Workers
Occupational Therapists
Psychologists